Cited by 84Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment ResearchMedical Imaging Techniques and Applications

Reduced Synaptic Density in Patients with Lewy Body Dementia: An [ 11 C ] UCB‐J PET Imaging Study

Open access
Andersen, Katrine B., Hansen, Allan K., Damholdt, Malene F., Horsager, Jacob, Skjærbæk, Casper, Gottrup, Hanne, Klit, Henriette, Schacht, Anna Christina +3 more·2021·Movement Disorders

Abstract

Background: Patients with Parkinson's disease (PD) often develop dementia, but the underlying substrate is incompletely understood. Generalized synaptic degeneration may contribute to dysfunction and cognitive decline in Lewy body dementias, but in vivo evidence is lacking. Objective: The objective of this study was to assess the density of synapses in non‐demented PD (nPD) subjects (N = 21), patients with PD‐dementia or Dementia with Lewy bodies (DLB) (N = 13), and age‐matched healthy controls (N = 15). Method: Using in vivo PET imaging and the novel synaptic‐vesicle‐glycoprotein 2A (SV2A) radioligand [11C]UCB‐J, SUVR‐1 values were obtained for 12 pre‐defined regions. Volumes‐of‐interest were defined on MRI T1 scans. Voxel‐level between‐group comparisons of [11C]UCB‐J SUVR‐1 were performed. All subjects underwent neuropsychological assessment. Correlations between [11C]UCB‐ J PET and domain‐specific cognitive functioning were examined. Results: nPD patients only demonstrated significantly reduced SUVR‐1 values in the substantia nigra (SN) compared to HC. DLB/PDD patients demonstrated reduced SUVR‐1 values in SN and all cortical VOIs except for the hippocampus and amygdala. The voxel‐based analysis supported the VOI results. Significant correlation was seen between middle frontal gyrus [11C]UCB‐J SUVR‐1 and performance on tests of executive function. Conclusion: Widespread cortical reduction of synaptic density was documented in a cohort of DLB/PDD subjects using in vivo [11C]UCB‐J PET. Our study confirms previously reported synaptic loss in SN of nPD patients. [11C]UCB‐J binding in selected cortical VOIs of the DLB/PDD patients correlated with their levels of cognitive function across relevant neuropsychological domains. These findings suggest that the loss of synaptic density contributes to cognitive impairment in nPD and DLB/PDD. © 2021 International Parkinson and Movement Disorder Society

Integrity signals

Registry

Crossref · 10.1002/mds.28617

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Severe synaptic loss has been observed using 11C-UCBJ PET in series of cases with DLB, FTD, PD, PDD, PSP, CBD, and C9Orf72 mutation carriers.

    “while severe synaptic loss has been observed using 11C -UCBJ PET in series of cases with DLB, FTD, PD, PDD, PSP, CBD and C9Orf72 mutation carriers [205–209].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Andersen, K. B., Hansen, A. K., Damholdt, M. F., Horsager, J., Skjærbæk, C., Gottrup, H., Klit, H., Schacht, A. C., Danielsen, E. H., Brooks, D. J., & Borghammer, P.
Affiliations
  • Aarhus University Hospital (DK)
  • Aarhus University (DK)
Corresponding author
Andersen, Katrine B.
Venue
Movement Disorders
Publisher
Wiley
Published
2021-04-25
Volume
36
Issue
9
Pages
2057-2065
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W3158605453
Cited by
84
References
4
Citations by year
2026: 12 · 2025: 16 · 2024: 25 · 2023: 15 · 2022: 13 · 2021: 3
FWCI
6.70
Type
journal article
Language
en
Open access
Locations
  • Movement Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
Lundbeck Foundation (R276‐2018‐294)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
dementia with Lewy bodies, Parkinson's disease dementia, synaptic density, synaptic loss, [11C]UCB-J, substantia nigra, executive function, cognitive impairment, positron emission tomography
MeSH terms
Alzheimer Disease, Humans, Parkinson Disease, Lewy Body Disease, Positron-Emission Tomography, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review